Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation [PMID: 21840572] Laboratory literature summary: Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats studied with heparin, warfarin or aspirin
It does not appear toxic, does not accumulate in tissues, and has been well tolerated in trials
This multi-point intervention explains why the peptide often succeeds where single-mechanism treatments fail
The products should not be used as a food, drug, cosmetic, or other household use
Taxes While ReliAscent is not a tax CPA firm, we are following the development of IRS Section 174
US$ 26.31
US$ 22.58
US$ 25.29
US$ 24.18
US$ 25.58
US$ 24.40
US$ 28.66
US$ 22.94
US$ 22.82
